Birth Outcomes of Pregnant Women Infected with COVID-19 in Highland Areas of China from 2020 to 2022: A Retrospective Analysis
Aiming Lv,Bian Ba Zhuo Ma,De Qiong,Da Wa Zhuo Ma,Pu Bu Zhuo Ma,Donghua Yao,Da Zhen,Chunxiu Tang,Bian Ba Zhuo Ma,Youzhi Lu,Long Cai,Yutong Zhang,Jinyu Yin,Tong Ding,Lang Ji Qu Zhen,Da Wa Cang,Meng Wu,Yulan Chen,Ye Li
DOI: https://doi.org/10.2147/idr.s435751
2024-03-09
Infection and Drug Resistance
Abstract:Aiming Lv, 1, 2 Bian Ba Zhuo Ma, 3 De Qiong, 2 Da Wa Zhuo Ma, 2 Pu Bu Zhuo Ma, 3 Donghua Yao, 4 Da Zhen, 2 Chunxiu Tang, 2 Bian Ba Zhuo Ma, 2 Youzhi Lu, 2 Long Cai, 2 Yutong Zhang, 2 Jinyu Yin, 2 Tong Ding, 2 Lang Ji Qu Zhen, 2 Da Wa Cang, 5 Meng Wu, 5 Yulan Chen, 5 Ye Li 1 1 Department of Obstetrics and Gynecology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China; 2 Department of Obstetrics and Gynecology, Women and Children's Hospital of Tibet Autonomous Region, Lhasa City, TB, People's Republic of China; 3 Department of Obstetrics and Gynecology, Lhasa People's Hospital, Lhasa, TB, 850000, People's Republic of China; 4 Department of Obstetrics and Gynecology, Nyingchi People's Hospital, Nyingchi City, TB, People's Republic of China; 5 Department of Obstetrics and Gynecology, Tibet University Medical School, Lhasa City, TB, People's Republic of China Correspondence: Ye Li, Department of Obstetrics and Gynecology, Beijing Hospital, National center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, China, No. 1 DaHua Road, Dong Dan, Beijing, 100730, People's Republic of China, Tel +86 13611118475, Fax +86 10 85136220, Email Purpose: To explore the effect of coronavirus disease 2019 (COVID-19) infection on neonates in plateau regions. Methods: Cases of newborns born to pregnant women infected with COVID-19 who received prenatal care or treatment at the Women and Children's Hospital of the Tibet Autonomous Region and the Lhasa People's Hospital between January 2020 and December 2022 (infected group) and newborns born to healthy pregnant women (non-infected group) who were included by age, underlying disease and length of hospital stay were retrospectively collected. According to the inclusion and exclusion criteria, 381 patients in the infected group and 314 patients in the non-infected group were included in the study. Results: The results of multivariate analysis showed that admission to the neonatal intensive care unit (OR = 3.342, 95% CI = 1.564– 6.764), shortness of breath (OR = 2.853, 95% CI = 1.789– 3.154), irregular breathing (OR = 2.465, 95% CI = 1.879– 4.112) and neonatal jaundice (OR = 2.324, 95% CI = 1.989– 2.445) were the factors influencing the low Apgar scores of neonates in the infected group (all P < 0.05). Conclusion: Neonates born to pregnant women infected with COVID-19 had lower Apgar scores and higher incidences of complications, such as shortness of breath, groaning, irregular breathing and neonatal jaundice, than newborns born to pregnant women not infected with COVID-19. Keywords: COVID-19, pregnant women, newborn The pathogen of coronavirus disease 2019 (COVID-19) is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belonging to the group of betacoronaviruses that includes other members, such as the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) that became widespread across the globe with high morbidity and mortality. 1–3 The SARS-CoV-2 invades cells by binding the spike protein (S protein) with the angiotensin-converting enzyme 2 (ACE2). 4 The SARS-CoV-2 and the SARS-CoV have a similar affinity to the ACE2, but the former has a high incidence of infection due to its mutability. 5–7 The physiological changes in immune, respiratory and circulatory systems during pregnancy make pregnant women susceptible to pathogens and intolerant to hypoxia. 8–10 Pregnant women have a higher risk of viral infections, complications and adverse clinical and pregnancy outcomes compared with the general population. 11 Controversy exists about whether a novel coronavirus infection impacts neonatal outcomes. 12–16 Some studies have found no significant increase in the incidence of adverse neonatal outcomes in pregnant women who tested positive for COVID-19 compared with pregnant women who tested negative. 17,18 Conversely, some studies have shown an increased risk of adverse neonatal outcomes in pregnant women who tested positive for COVID-19. 19,20 The COVID-19 vaccination effectively reduces the incidence of critical and fatal cases. However, neonates cannot be vaccinated against COVID-19, have low immunity 21 and, as a consequence, are vulnerable to epidemics. Infected newborns may die, 22 and COVID-19 may also cause systemic diseases ac -Abstract Truncated-
pharmacology & pharmacy,infectious diseases